SEVERE COMBINED IMMUNODEFICIENCY
Clinical trials for SEVERE COMBINED IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new SEVERE COMBINED IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for SEVERE COMBINED IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell filter aims to reduce transplant complications for rare blood diseases
Disease control AVAILABLEThis expanded access program offers a special stem cell filtering technique (CD34+ selection) to patients with severe blood disorders like sickle cell disease and immune deficiencies. The goal is to lower the risk of graft-versus-host disease, a serious complication where donor c…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY
Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New gene therapy offers hope for babies with 'Bubble Boy' disease
Disease control Recruiting nowThis study tests a gene therapy for Artemis-deficient SCID, a severe immune disorder where babies cannot fight infections. Doctors take the child's own blood stem cells, add a working copy of the faulty gene, and return them to the body after mild chemotherapy. The goal is to bui…
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Scientists hunt for genetic clues behind rare immune disorder
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of severe combined immunodeficiency (SCID), a rare condition where the immune system doesn't work properly. Researchers will collect blood samples from up to 100 patients and their relatives to analyze DNA and other factors. The goal …
Matched conditions: SEVERE COMBINED IMMUNODEFICIENCY
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC